Narcolepsy Drugs Market Size, Share, Growth Analysis, By Disease Type(Daytime Extreme Sleepiness, Cataplexia, and Other Disease Type), By Therapeutics Type(Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor), By Region - Industry Forecast 2024-2031

Narcolepsy Drugs Market Drivers

Growing Mental Health Awareness 

• Mental health awareness has increased rapidly in recent years as the incidence of stress, anxiety, and other mental health disorders such as narcolepsy has also risen. Launch of new efforts and initiatives to solve these mental health issues and help patients affected from the same are expected to bolster the global narcolepsy drugs market outlook in the future.   

Emphasis on Lifestyle Improvement 

• People affected by narcolepsy have significantly reduced quality of life as they experience extreme daytime sleepiness and sudden muscle weaknesses. Efforts to promote healthy lifestyles and reduce the sedentary nature of people’s life are expected to promote the sales of narcolepsy drugs over the coming years.  

Narcolepsy Drugs Market Restraints 

Limited Awareness in Developing Regions 

• Awareness regarding symptoms and effects of narcolepsy is quite limited in most parts of the world, especially in developing and underdeveloped regions.  This lack of awareness causes most narcoleptic patients going undetected and void of treatment thereby hurting the demand for narcolepsy drugs as well. Awareness programs and campaigns can easily help in overcoming this restraint.  

Side Effects of Narcolepsy Treatment 

• Extensive use of narcolepsy drugs has been linked to cardiovascular issues, nervous system disturbances, and also the risk of dependence leading to substance abuse as well. Increasing awareness regarding these ill effects associated with the use of narcolepsy drugs is projected to slow down the overall narcolepsy drugs market forecast in the long run.